Check out our most popular compounded medications! Get Started
Zonisamide 10 mg/ml Oral Liquid is a specially compounded medication designed for oral use, offering a precise and manageable method of drug delivery. This liquid formulation is particularly beneficial for patients who experience difficulty swallowing pills or capsules, such as those in pediatric and geriatric groups. Zonisamide is an anticonvulsant medication primarily used to treat epilepsy, a neurological disorder characterized by recurrent seizures.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Zonisamide 10 mg/ml Oral Liquid is a custom-prepared medication designed for oral use, specifically tailored to meet the needs of patients who require zonisamide in a liquid form. This formulation is particularly beneficial for individuals who have difficulty swallowing pills, such as children and the elderly, or for those with conditions that impair their ability to ingest solid dosage forms. The liquid formulation ensures that patients receive an accurate dose of zonisamide, which is crucial for maintaining therapeutic levels of the medication in the body.
Zonisamide is an antiepileptic drug (AED) that is used to manage and treat seizures in patients with epilepsy. It works by modulating sodium and calcium channels in the brain, which helps to stabilize neuronal membranes and suppress the abnormal electrical activity that leads to seizures. By providing zonisamide in a liquid form, it allows for flexible dosing that can be easily adjusted according to the specific needs of the patient, which is particularly important in the management of epilepsy where individual response to medication can vary significantly.
The liquid formulation should be measured with an appropriate measuring device to ensure the correct dose is administered. For prescribers, it is crucial to consider the patient's weight, age, and renal function when determining the appropriate dose of zonisamide. Regular monitoring of the patient's response to therapy, as well as any potential side effects, is recommended to ensure optimal treatment outcomes.
Bayview Pharmacy's team of compounding pharmacists is committed to providing high-quality, patient-specific formulations like Zonisamide 10 mg/ml Oral Liquid. We are available to answer any questions and provide additional information to both patients and healthcare providers interested in utilizing this formulation for the treatment of epilepsy.
Zonisamide is an antiepileptic drug used to treat seizures in patients with epilepsy. As with any medication, zonisamide can interact with other drugs, which may affect how it works or increase the risk of serious side effects. It is important for both patients and prescribers to be aware of these potential interactions to ensure the safe and appropriate use of zonisamide oral liquid.
One of the primary concerns with zonisamide is its interaction with other central nervous system (CNS) depressants. When taken with other CNS depressants such as benzodiazepines, barbiturates, or alcohol, the sedative effects can be enhanced, leading to increased drowsiness, dizziness, or difficulty concentrating. Patients should be advised to avoid or limit the use of alcohol while taking this medication and to be cautious when taking other CNS depressants.
Zonisamide is a weak carbonic anhydrase inhibitor, and its use with other carbonic anhydrase inhibitors (e.g., topiramate, acetazolamide) can increase the risk of metabolic acidosis. If these medications must be used together, monitoring of serum bicarbonate levels is recommended, and patients should be informed of the signs and symptoms of metabolic acidosis, such as irregular heartbeat, tiredness, loss of appetite, and changes in breathing.
Additionally, zonisamide is metabolized by the liver and may interact with other drugs that affect liver enzymes, particularly those that induce or inhibit cytochrome P450 isoenzymes. For example, drugs that induce CYP3A4, such as rifampin or St. John's Wort, may decrease the plasma concentration of zonisamide, potentially reducing its efficacy. Conversely, drugs that inhibit CYP3A4, such as ketoconazole or grapefruit juice, may increase zonisamide levels, leading to toxicity. It is important to monitor for side effects and adjust the zonisamide dose as necessary when starting or stopping such medications.
Oral contraceptives may have reduced efficacy when taken with zonisamide, so alternative or additional non-hormonal birth control methods should be considered. Patients should be counseled on this potential interaction to prevent unintended pregnancies.
Patients with renal or hepatic impairment may require dose adjustments, as zonisamide clearance can be affected by changes in organ function. Careful monitoring and dose titration are advised in these populations.
Lastly, zonisamide may interact with other antiepileptic drugs (AEDs), altering their levels or effects. When adding or discontinuing AEDs, it is important to monitor seizure control and drug concentrations, adjusting doses as necessary to maintain therapeutic levels without causing toxicity.
It is crucial for patients to inform their healthcare provider of all medications they are taking, including prescription drugs, over-the-counter medications, and herbal supplements, to avoid potential drug interactions. If you have any questions or concerns about the use of zonisamide oral liquid or its interactions with other medications, please reach out to us at Bayview Pharmacy for further assistance.
Zonisamide is an antiepileptic drug (AED) that is used to manage and treat certain types of seizures, such as partial seizures, in both adults and children. The mechanism by which zonisamide exerts its antiseizure effect is not completely understood, but it is believed to involve the modulation of several neuronal ion channels. Zonisamide is known to block sodium channels in the brain, which helps to stabilize neuronal membranes and prevent the repetitive firing of neurons that can lead to seizures. Additionally, zonisamide has been found to reduce T-type calcium channel activity, which is thought to contribute to its antiseizure properties. Furthermore, zonisamide may enhance the action of the neurotransmitter gamma-aminobutyric acid (GABA), which is an inhibitory neurotransmitter that can suppress seizure activity.
The formulation of zonisamide as a 10 mg/ml oral liquid provides a flexible dosing option for patients who may have difficulty swallowing tablets or capsules, such as young children, the elderly, or those with neurological disorders that affect swallowing. The liquid form allows for precise dosing, which is critical in the management of epilepsy where maintaining the correct dosage is essential for controlling seizures without causing excessive side effects. The oral liquid formulation is also beneficial for patients who require a customized dosage that is not available in standard tablet or capsule sizes.
When administered, the zonisamide oral liquid is absorbed from the gastrointestinal tract and reaches peak plasma concentrations within 2 to 6 hours. The drug is metabolized by the liver and has a relatively long half-life, which allows for once or twice daily dosing in most cases.
It is important for patients and prescribers to understand that while zonisamide can significantly reduce the frequency of seizures, it is not a cure for epilepsy. Patients should also be aware of potential side effects, which can include drowsiness, dizziness, and cognitive impairment, among others. Regular monitoring and communication with a healthcare provider are essential to ensure the safe and appropriate use of zonisamide oral liquid.
If you have any questions about the zonisamide 10 mg/ml oral liquid formulation or its use in treating epilepsy, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to manage your or your loved one's health condition effectively.
Zonisamide 10 mg/ml Oral Liquid is a specially prepared medication in liquid form designed to be taken by mouth. It's used to provide an accurate dose of zonisamide, which is commonly used to treat seizures. This liquid dosage form is ideal for patients who have difficulty swallowing pills, such as children and the elderly.
Store the Zonisamide Oral Liquid at room temperature, away from light and moisture. Do not store in the bathroom, and be sure to keep it out of reach of children and pets. Always store the medication in its original container.
Take Zonisamide Oral Liquid precisely as your doctor has prescribed. Typically, the medication is measured using the provided dosing syringe or dropper for accuracy. It can be taken with or without food. Always follow the specific administration instructions provided by your pharmacist or healthcare provider.
Before mixing Zonisamide Oral Liquid with food or beverages, consult with your pharmacist or healthcare provider for advice. Certain foods or drinks may affect the absorption or taste of the medication.
The effectiveness of Zonisamide should be comparable between the oral liquid and tablet forms if taken as prescribed. However, the liquid form can be particularly beneficial for those who have issues with swallowing tablets.
If you miss a dose of Zonisamide Oral Liquid, take it as soon as you remember. However, if it's almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to catch up.
If an overdose is suspected, contact your local poison control center or seek emergency medical attention immediately. Overdose symptoms may include breathing difficulties, loss of coordination, and severe drowsiness.
Yes, as with any medication, Zonisamide Oral Liquid can cause side effects. Common side effects may include drowsiness, dizziness, headache, and loss of appetite. If you experience severe or persistent side effects, contact your healthcare provider immediately.
Although rare, an allergic reaction to Zonisamide Oral Liquid is possible. Symptoms of an allergic reaction include rash, itching, swelling of the face, tongue, or throat, severe dizziness, and trouble breathing. If you experience these symptoms, seek medical attention immediately.
You will know Zonisamide Oral Liquid is working if you experience a reduction in the frequency or intensity of seizures. Keep a record of your seizures to track the medication's effectiveness, and discuss any changes with your healthcare provider.
Pregnancy may pose specific risks, and it is essential to discuss the use of Zonisamide Oral Liquid with your healthcare provider if you are pregnant or planning to become pregnant. Your provider will help you weigh the benefits and risks associated with taking the medication during pregnancy.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
